Suppr超能文献

抗精神病药物在人多巴胺D2受体上的受体储备依赖性特性。

Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.

作者信息

Tadori Yoshihiro, Forbes Robert A, McQuade Robert D, Kikuchi Tetsuro

机构信息

Quests Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, 771-0192, Japan.

出版信息

Eur J Pharmacol. 2009 Apr 1;607(1-3):35-40. doi: 10.1016/j.ejphar.2009.02.007. Epub 2009 Feb 13.

Abstract

Aripiprazole is the first dopamine D(2)/D(3) receptor partial agonist approved for use in the treatment of psychiatric disorders including schizophrenia, bipolar disorder, and unipolar depression in the US. Aripiprazole has demonstrated a relatively favorable side effect profile compared to other commonly prescribed antipsychotics, including a low propensity for treatment-limiting extrapyramidal symptoms, hyperprolactinemia, and body weight gain. In an effort to elucidate aripiprazole's pharmacological activity in relation to clinically relevant fluctuation of dopamine D(2) receptor reserves, we compared the properties of aripiprazole to other antipsychotics, quetiapine, clozapine, olanzapine, ziprasidone, risperidone and haloperidol, a dopamine D(2) receptor partial agonist, bifeprunox, dopamine D(3) receptor modulators, BP897 (N-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]naphthalene-2-carboxamide) and GR103691 (4'-Acetyl-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]biphenyl-4-carboxamide), and a 5-HT(1A) partial agonist, buspirone using forskolin-stimulated cAMP accumulation in clonal Chinese hamster ovary cell lines expressing low and high densities of human dopamine D(2S) receptors (hD(2S)-Low and hD(2S)-High, respectively). In hD(2S)-Low cells lacking receptor reserves for dopamine, all drugs antagonized dopamine responses, and their potencies correlated well with respective affinities. In hD(2S)-High cells possessing receptor reserves, all antipsychotics except aripiprazole antagonized dopamine responses, and their antagonist potencies were less than those in hD(2S)-Low cells treated with the equal dopamine concentration. In contrast, aripiprazole and bifeprunox acted as full agonists. BP897, GR103691 and buspirone acted as partial agonists. These data suggest that the level of receptor reserves influences antagonist potencies and side effects associated with antipsychotics. Aripiprazole's unique receptor reserve dependent properties may account for its favorable tolerability in the clinical setting.

摘要

阿立哌唑是美国首个被批准用于治疗包括精神分裂症、双相情感障碍和单相抑郁症在内的精神疾病的多巴胺D(2)/D(3)受体部分激动剂。与其他常用的抗精神病药物相比,阿立哌唑已显示出相对良好的副作用谱,包括治疗限制性锥体外系症状、高催乳素血症和体重增加的倾向较低。为了阐明阿立哌唑与多巴胺D(2)受体储备的临床相关波动有关的药理活性,我们将阿立哌唑的特性与其他抗精神病药物、喹硫平、氯氮平、奥氮平、齐拉西酮、利培酮和氟哌啶醇、多巴胺D(2)受体部分激动剂比氟普诺克斯、多巴胺D(3)受体调节剂BP897(N-[4-[4-(2-甲氧基苯基)-1-哌嗪基]丁基]萘-2-甲酰胺)和GR103691(4'-乙酰基-N-[4-[4-(2-甲氧基苯基)哌嗪-1-基]丁基]联苯-4-甲酰胺)以及5-HT(1A)部分激动剂丁螺环酮进行了比较,使用福斯高林刺激表达低密度和高密度人多巴胺D(2S)受体(分别为hD(2S)-Low和hD(2S)-High)的克隆中国仓鼠卵巢细胞系中的cAMP积累。在缺乏多巴胺受体储备的hD(2S)-Low细胞中,所有药物均拮抗多巴胺反应,其效力与各自的亲和力密切相关。在具有受体储备的hD(2S)-High细胞中,除阿立哌唑外的所有抗精神病药物均拮抗多巴胺反应,且其拮抗效力低于用等量多巴胺浓度处理的hD(2S)-Low细胞中的效力。相比之下,阿立哌唑和比氟普诺克斯表现为完全激动剂。BP897、GR103691和丁螺环酮表现为部分激动剂。这些数据表明,受体储备水平影响与抗精神病药物相关的拮抗效力和副作用。阿立哌唑独特的受体储备依赖性特性可能解释了其在临床环境中的良好耐受性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验